186550-26-5 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
3'-METHOXY-BIPHENYL-4-SULFONYL CHLORIDE is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals for its ability to react with various functional groups, facilitating the creation of a wide range of compounds with potential therapeutic and pesticidal properties.
Used in Dye and Pigment Manufacturing:
In the dye and pigment industry, 3'-METHOXY-BIPHENYL-4-SULFONYL CHLORIDE is used as a key component in the production of various dyes and pigments, contributing to their color and stability.
Used as a Reagent in Organic Synthesis:
3'-METHOXY-BIPHENYL-4-SULFONYL CHLORIDE is utilized as a reagent in organic synthesis, where its sulfonyl chloride group can be used to introduce sulfonyl functionalities into target molecules, enhancing their reactivity and properties for specific applications.
Used in the Synthesis of Biologically Active Compounds:
Due to its versatile reactivity, 3'-METHOXY-BIPHENYL-4-SULFONYL CHLORIDE is considered a valuable starting material for the synthesis of biologically active compounds, which can be further developed into potential drugs or other bioactive substances.
Check Digit Verification of cas no
The CAS Registry Mumber 186550-26-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,6,5,5 and 0 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 186550-26:
(8*1)+(7*8)+(6*6)+(5*5)+(4*5)+(3*0)+(2*2)+(1*6)=155
155 % 10 = 5
So 186550-26-5 is a valid CAS Registry Number.
186550-26-5Relevant academic research and scientific papers
SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS
-
, (2008/06/13)
The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More especially, they are Factor Xa inhibitors. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, conditions which can be ameliorated by the administration of an inhibitor of Factor Xa.
